NIAID | Technology Transfer

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Finland
00989184.7
Filed on 2000-09-22

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Denmark
00989184.7
Filed on 2000-09-22

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Cyprus
00989184.7
Filed on 2000-09-22

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Belgium
00989184.7
Filed on 2000-09-22

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Austria
00989184.7
Filed on 2000-09-22

Development of a Preventive Vaccine for Filovirus Infection in Primates

Read more about Development of a Preventive Vaccine for Filovirus Infection in Primates

European Patent
05013732.2
Filed on 2002-09-24

Negative Strand RNA Virus Replicon

Read more about Negative Strand RNA Virus Replicon

Patent Cooperation Treaty
PCT/US2004/018783
Filed on 2004-06-14

Major Neutralization Site Of Hepatitis E Virus And Use Of This Neutralization Site In Methods Of Vaccination And In Methods Of.....

Read more about Major Neutralization Site Of Hepatitis E Virus And Use Of This Neutralization Site In Methods Of Vaccination And In Methods Of.....

US Patent 7,148,323
Filed on 2005-02-09

Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses

Read more about Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses

India
165/DELNP/2008
Filed on 2008-07-01

Multimeric Protein Toxins To Target Cells Having Multiple Identifying Characteristics

Read more about Multimeric Protein Toxins To Target Cells Having Multiple Identifying Characteristics

Patent Cooperation Treaty
PCT/US2005/04216
Filed on 2005-02-09

Subscribe to NIAID